DEBORAH VOUTOUR: Open Payments
NPI 1508890674 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,117 in 74 payments from 18 companies in 2025. Trend: 2023 $635 · 2024 $122 · 2025 $2,117
Food & beverage: $1,919Education: $197
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $635 |
| GlaxoSmithKline, LLC. | 15 | $304 |
| Regeneron Healthcare Solutions, Inc. | 7 | $244 |
| Insmed, Inc. | 8 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $138 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Grifols USA, LLC | 4 | $88 |
| GENZYME CORPORATION | 4 | $84 |
| Merck Sharp & Dohme LLC | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $58 |
Products named: AIRSUPRA, DUPIXENT, TRELEGY ELLIPTA, Arikayce, GLASSIA, BREZTRI, Prolastin-C Liquid, FASENRA.
Industry payments across FL — which companies pay providers there.
